Transplantation, AutologousKidney TransplantationBlood Transfusion, AutologousTransplantsGraft RejectionBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft SurvivalImmunosuppressive AgentsHeart TransplantationTissue DonorsTransplantationTreatment OutcomeLung TransplantationTime FactorsRetrospective StudiesStem Cell TransplantationTissue and Organ ProcurementCyclosporineImmunosuppressionCombined Modality TherapyPostoperative ComplicationsTransplantation ConditioningTacrolimusLiving DonorsWaiting ListsMelphalanCytomegalovirus InfectionsFollow-Up StudiesRecurrenceHistocompatibility TestingGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationFetal Tissue TransplantationT-LymphocytesMultiple MyelomaTransplantation ImmunologySurvival AnalysisCyclophosphamideWhole-Body IrradiationLymphoma, Non-HodgkinBone Marrow PurgingMycophenolic AcidSurvival RateAntineoplastic Combined Chemotherapy ProtocolsImmunocompromised HostCadaverLymphocyte Culture Test, MixedKidney Failure, ChronicHLA AntigensCytotoxicity, ImmunologicHematologic NeoplasmsCarmustineCell TransplantationLiver FailureLymphocyte ActivationRisk FactorsProspective StudiesHodgkin DiseaseT-Lymphocytes, CytotoxicHematopoietic Stem Cell MobilizationSalvage TherapyDisease-Free SurvivalHeart-Lung TransplantationHistocompatibilityTransplantation, HeterotopicBrain Tissue TransplantationOpportunistic InfectionsEtoposideCells, CulturedAntilymphocyte SerumAntigens, CD34Remission InductionPrognosisTransplantation, IsogeneicAcute DiseaseBusulfanCytomegalovirusBronchiolitis ObliteransThiotepaAntigens, NeoplasmDendritic CellsTransplantation ToleranceBiopsyHematopoietic Stem CellsImmunotherapy, AdoptiveAntibodies, MonoclonalLeukemiaLymphoproliferative DisordersTissue TransplantationImmunotherapyIsoantibodiesKidneyCancer VaccinesCytarabineBone TransplantationBK VirusFlow CytometryLymphocytes